Show metadata Hide metadata

(19)

(11)

2 778 514

(13)

(51)

IPC

C07K7/06(2006-01-01)

C07K7/08(2006-01-01)

A61K38/08(2006-01-01)

A61K38/10(2006-01-01)

A61K47/64(2017-01-01)

A61P7/00(2006-01-01)

(21) (22)

Application

2018136750, 2015-06-12

(24)

Start date

2015-06-12

(22)

Actual filing date

2015-06-12

(45)

Published

2022-08-22

(72)

Inventor

Khorti, Mishell DenizDkhamnaskar, Ketki AskhokElbom, DenielDzhozefson, KristoferLarson, Kelli KroninMa, ChzhunNims, Natan IzekilRikardo, AlonsoSejb, KetlinTan, Go-TsinTreko, Duglas A.Van, ChzhaolinE, PinChzhen, KhunPerlmutter, Sara ZhaklinKhammer, Robert Pol

(73)

Holder

Ra Pharmaceuticals, Inc.

COMPLEMENT ACTIVITY MODULATION Russian patent published in 2022 - IPC C07K7/06 C07K7/08 A61K38/08 A61K38/10 A61K47/64 A61P7/00

Abstract RU 2778514 C2

FIELD: biotechnology.

SUBSTANCE: present invention relates to polypeptides, which are complement activity modulators. Polypeptides show C5-inhibitory activity.

EFFECT: obtaining polypeptides for complement activity modulation.

11 cl, 7 dwg, 18 tbl, 22 ex

Similar patents RU2778514C2

Title	Year	Author	Number
MODULATION OF COMPLEMENT ACTIVITY	2015	Khorti Mishell Deniz Dkhamnaskar Ketki Askhok Elbom Deniel Dzhozefson Kristofer Larson Kelli Kronin Ma Chzhun Nims Natan Izekil Rikardo Alonso Sejb Ketlin Tan Go-Tsin Treko Duglas A. Van Chzhaolin E Pin Chzhen Khun Perlmutter Sara Zhaklin Khammer Robert Pol	RU2670988C2
PEPTIDIC INTERLEUKIN-23 RECEPTOR INHIBITORS FOR ORAL ADMINISTRATION AND USE THEREOF FOR TREATING INFLAMMATORY INTESTINAL DISEASES	2015	Bourne, Gregory Bhandari, Ashok Cheng, Xiaoli Frederick, Brian Troy Zhang, Jie Patel, Dinesh V. Liu, David	RU2736637C2
KV1_3 BLOCKERS	2020	Munch, Henrik Fischer Jensen, Rasmus Bugge Madsen, Jens Kvist	RU2825633C1
COMPOUND WHICH IS CALCIUM-SENSITIVE RECEPTOR AGONIST, AND USE THEREOF	2020	Wu Fangzhou Zhang Jin Gao Fei Wu Ran Liao Cheng Wang Lei	RU2827834C1
GIP AGONIST COMPOUNDS AND METHODS	2015	Shelton Pernilla Tofteng Norregaard Pia Deryabina Mariya Aleksandrovna Larsen Byarn Dyu Fog Dzhejkob Ulrik	RU2716985C2
ENGINEERED pH-DEPENDENT ANTI-CD3 ANTIBODIES, AS WELL AS METHODS FOR PRODUCTION AND USE THEREOF	2020	Geoghegan, James Prinz, Bianka Pejchal, Robert	RU2832079C2
TRISPECIFIC MOLECULES BINDING BCMA, AND WAYS OF USE THEREOF	2020	Granda, Brajan Blankenship, Dzhon Ejbyudzhoub, Aida Fleming, Toni Lu, Khajkhoj Khuan, Lu Khong, Konni Kholmberg, Brajan	RU2829901C2
MULTI-RECEPTOR AGONIST AND MEDICAL USE THEREOF	2020	Wu Fangzhou Wang Lei Liu Xiao Wu Ran Hua Haiqing Bao Rudi Wang Xiaolei	RU2816492C2
STRUCTURES HAVING SIRP-ALPHA DOMAIN OR ITS VERSION	2016	Ponz Khaume Deming Laura Gudman Kori Sim Bang Dzhanet Kauder Stiven Elliot Van Khun Ko Trejsi Chia-Chien	RU2740672C2
CD40L-SPECIFIC FRAMEWORK STRUCTURES DERIVED FROM Tn3, AND METHODS OF USE THEREOF	2012	Kojl, Entoni Baka, Manuel Tisted, Tomas Drabik, Stejsi Grinberg, Lyuba Novarra, Shabazz Oganesyan, Vakhekh Kherbst, Ronald Spenser, Devid, Kennet	RU2826189C2

RU 2 778 514 C2

Authors

Khorti, Mishell Deniz

Dkhamnaskar, Ketki Askhok

Elbom, Deniel

Dzhozefson, Kristofer

Larson, Kelli Kronin

Ma, Chzhun

Nims, Natan Izekil

Rikardo, Alonso

Sejb, Ketlin

Tan, Go-Tsin

Treko, Duglas A.

Van, Chzhaolin

E, Pin

Chzhen, Khun

Perlmutter, Sara Zhaklin

Khammer, Robert Pol

Dates

2022-08-22—Published

2015-06-12—Filed